Possibility of using dabigatran in patients with atrial fibrillation and acute coronary syndrome and PCI

This article is devoted to the problem of combined antithrombotic therapy in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) due to acute coronary syndrome (ACS). Traditionally, these patients require an oral anticoagulant (OAC) to prevent stroke and dual a...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autor: A. D. Erlich
Médium: Artigo
Jazyk:Russo
Vydáno: Remedium Group LLC 2019-04-01
Edice:Медицинский совет
Témata:
atrial fibrillation
acute coronary syndrome
pci
anticoagulant
dabigatran
On-line přístup:https://www.med-sovet.pro/jour/article/view/2911
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky